This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Sanofi-Aventis Recherche & Développement. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marie-Laure Ozoux: Innovator in Therapeutic Applications
Introduction: Marie-Laure Ozoux is an accomplished inventor based in Paris, France. She is currently associated with Sanofi, a global healthcare company. Although she has not yet been granted any patents, her work focuses on significant advancements in therapeutic applications.
Latest Patent Applications: Marie-Laure Ozoux has been involved in several noteworthy patent applications. One of her latest applications is titled "CRF2 Receptor Agonists and Their Use in Therapy." This disclosure provides compounds that are peptides comprising a specific amino acid sequence or pharmaceutically acceptable salts. These compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are particularly useful in the treatment or prevention of cardiovascular diseases, obesity, and diabetes. Another significant application is "Specific Anti-CD38 Antibodies for Treating Human Cancers." This disclosure concerns an antibody that specifically binds to CD38, capable of inducing apoptosis and mediating cytotoxicity. The disclosed antibody may be used as a medicament for treating CD38+ multiple myeloma in humans.
Conclusion: Marie-Laure Ozoux is a promising inventor whose work in therapeutic applications holds great potential for future medical advancements. Her contributions to the field, particularly in the development of innovative compounds and antibodies, are noteworthy and reflect her commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile